Deep Tech Startups

Bioflyte provides chemical and biological threat detection solutions for critical infrastructure and business operations, enabling organizations to monitor, identify and respond to bio/chem threats. The company serves government agencies, critical infrastructure operators, and other organizations responsible for security and safety.

4 investors

BIOIO develops a genetics-based platform for elucidating drug mechanisms of action, combining decades of research in pharmacology with big data and automation to accelerate drug discovery and development. The company serves pharmaceutical and biotech organizations seeking to understand how drugs work.

4 investors

The company builds "Biological Adapters" that integrate living neurons with AI foundation models to improve performance and reduce training cost, and it operates an algorithm discovery platform based on principles from biological neural systems. Its technology (TBC) targets applications such as computer vision, generative video, world models, robotics, and time-series prediction.

4 investors

Biomodal develops genomic and epigenomic sequencing technologies for life scientists and clinical researchers, enabling simultaneous analysis of genetic data and modified cytosine bases from a single DNA sample. The company's tools integrate pre- and post-sequencing workflows to capture both canonical and modified bases in the genome.

4 investors

Bitfury operates in the cryptocurrency/blockchain industry, with noted expertise in mining solutions and related technology infrastructure.

4 investors

Bliq develops autonomous driving technology to make private cars driverless. The company is building self-driving mobility solutions for European cities.

4 investors

Bliq works on driverless mobility, focusing on a scalable approach to autonomous transportation. The company is hiring and positions itself around advancing driverless vehicle technology.

4 investors

Bloom Science is a clinical-stage biotech company developing live biotherapeutic products that replicate the effects of the ketogenic diet through the gut-brain axis. Its lead program, BL-001, targets obesity and Dravet syndrome, supported by the IrisRx discovery platform that uses gut commensal microbes and synthetic biology to develop therapies for metabolic and neurological disorders.

4 investors

Warhead designs and manufactures advanced explosive ordnance systems for autonomous weapons platforms and drone applications. The company serves U.S. defense and military customers with transport-safe binary explosives and 3D-printed warheads for counter-UAS and autonomous systems.

4 investors

BreezeBio develops a programmable platform called NanoGalaxy for targeted delivery of genetic medicines, aiming to move genetic payloads to specific cells and tissues. The company operates in the biotech and genetic therapeutics space.

4 investors

Brightband is building an end-to-end AI Earth System for probabilistic weather and climate forecasting, and plans to open source benchmark datasets, models, and metrics for global weather forecasting. It offers AI weather modeling and forecasting tools to academia, government, and companies.

4 investors

BTRY develops solid-state battery technology designed to charge in one minute, extending electrification to applications previously limited by energy storage constraints. The company is a Swiss spin-off from Empa and ETH Zürich focused on manufacturing energy-dense batteries using a solvent-free process.

4 investors

Bullseye Biosciences uses in-cell directed evolution to discover functional therapeutic molecules against challenging intracellular targets such as protein–protein interactions and transcriptional regulation. Its platform selects molecules like macrocyclic and stapled peptides based on their biological effect inside living cells, with applications in oncology, immunology, and other serious diseases.

4 investors

Cailabs designs and manufactures photonics products based on its proprietary Multi-Plane Light Conversion (MPLC) technology for laser applications, serving the industrial, telecommunications, and space and defense sectors. The company builds products for industrial lasers, telecom networks, and satellite-to-ground laser communications.

4 investors

Calectra develops electrified, high-temperature industrial heat systems designed to reduce costs and emissions for industrial applications. The company serves energy-intensive manufacturing and industrial sectors requiring decarbonized thermal solutions.

4 investors

Cambridge GaN Devices is a fabless semiconductor company that develops energy-efficient GaN-based power devices for sustainable electronics. The company addresses global energy consumption and CO2 emissions through advanced power semiconductor solutions.

4 investors

CamGene Therapeutics develops RNA-based medicines, including mRNA, siRNA, and antisense oligonucleotides delivered via lipid nanoparticles, to treat the underlying cellular dysfunction that causes hearing loss. The company aims to modulate protein expression for regeneration and protection of cells in the cochlea as an accessible mass-market therapeutic.

4 investors

Canaery develops a nose-computer interface that combines animal olfaction with neurotechnology and AI to detect substances and diagnose diseases. The technology enables working animals to identify contraband, pests, and health conditions for security, pest control, and medical screening applications.

4 investors

Carba develops patented pyrolysis and carbon storage technology that converts waste biomass into stable carbon products for permanent carbon removal. The company targets climate change mitigation through modular reactor systems designed to achieve gigaton-scale carbon capture.

4 investors

Carbice manufactures aligned carbon nanotube-based thermal management products for aerospace, defense, and industrial power applications. The company operates the world's largest vertically aligned carbon nanotube production facility, located in Atlanta, Georgia, with additional operations in France and California.

4 investors

CarbonAmerica captures and stores carbon dioxide as part of climate change mitigation efforts.

4 investors

Cauldron is an Australian biotech company using precision fermentation to produce alternative proteins. The company has demonstrated process efficiencies in fermentation-derived protein production that can significantly reduce production costs.

4 investors

Cedana provides live migration technology for CPU and GPU containers that saves workload state, migrates jobs across nodes or clusters, and resumes execution without code changes. The platform serves compute infrastructure teams and enables workload portability across Kubernetes, SLURM, AWS, Google Cloud, and NVIDIA environments.

4 investors

CellChorus develops a visual AI platform called TIMING that performs high-throughput dynamic analysis of single cells, measuring cell activation, killing, and movement over time for biopharmaceutical research. The company serves biopharmaceutical companies and therapy developers seeking to understand cellular function and phenotype.

4 investors